Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/1/2025

Steroid Tapering in Crohn's Disease

Introduction to Steroid Tapering

  • The European Crohn's and Colitis Organisation recommends tapering the dose of prednisone gradually over 8-11 weeks starting from 40 mg daily, reducing by 5-10 mg every 1-2 weeks, as more rapid reduction is associated with early relapse 1, 2

Initial Dosing Strategy

  • The American Gastroenterological Association suggests starting with prednisone 40 mg daily as a single morning dose for patients with moderate to severe Crohn's disease, achieving approximately 60-83% remission rates depending on disease severity 1, 2
  • For more severe disease, consider 0.75 mg/kg/day (typically 40-60 mg for most adults) 2
  • For milder disease, 0.5 mg/kg/day may suffice 2
  • Never exceed 60 mg daily as higher doses increase adverse events without added benefit 2
  • Doses below 15 mg daily are ineffective for active disease 2

Structured Tapering Protocol

  • The optimal taper occurs over 8-11 weeks based on initial dose and disease severity, with the European Crohn's and Colitis Organisation explicitly stating that more rapid reduction associates with early relapse 1, 2, 3
  • A specific tapering schedule for a 40 mg starting dose is recommended, with reductions at weeks 1-2, 3-4, 5-6, 7, 8, 9, 10, and 11 3, 2

Identifying Steroid Dependency

  • Escalate to steroid-sparing therapy if any of the following occur: patient requires ≥2 corticosteroid courses within a calendar year, disease relapse occurs as steroid dose reduces below 15 mg, or relapse occurs within 6 weeks of stopping steroids 2

Steroid-Sparing Alternatives

  • When steroid dependency is identified, initiate one of the following rather than repeating steroid courses: azathioprine 2-2.5 mg/kg/day or 6-mercaptopurine 1-1.5 mg/kg/day, anti-TNF therapy, vedolizumab, or tofacitinib 1, 2

Critical Safety Considerations

  • Approximately 50% of patients experience short-term adverse effects including acne, edema, sleep disturbance, mood changes, glucose intolerance, and dyspepsia 2
  • High-dose steroids (≥20 mg daily) significantly increase infection risk, including respiratory tract infections, opportunistic infections, and septicemia 2
  • Add PCP prophylaxis if >3 weeks of immunosuppression expected at doses >30 mg prednisone equivalent daily, and start proton pump inhibitor for GI prophylaxis during corticosteroid use 2